Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
The headquarters of Valeant Pharmaceuticals International Inc., seen in Laval, Quebec November 9 2015. (CHRISTINNE MUSCH/REUTER)
The headquarters of Valeant Pharmaceuticals International Inc., seen in Laval, Quebec November 9 2015. (CHRISTINNE MUSCH/REUTER)

Investors take aim at bloated share grants to CEOs Add to ...

Subscribers Only

Some major shareholders are growing frustrated with the way companies are doling out share units as a major part of CEO pay, voting against pay packages at several large companies this year over concerns about equity grants that are oversized or poorly linked to performance.

While large investors have demanded that companies make more use of share units to ensure pay for chief executive officers is tied to performance, voting trends suggest they are also more willing to push back when share grants give CEOs big raises without a link to strong performance.

Report Typo/Error

Follow on Twitter: @JMcFarlandGlobe

 

More Related to this Story

Next story

loading

Trending

loading

Most popular videos »

More from The Globe and Mail

Most popular